Healthcare ❯ Pharmaceuticals

Diabetes Treatment

Weight Management Obesity Management Type 2 Diabetes GLP-1 Receptor Agonists GLP-1 Agonists Mounjaro Injectable Drugs Ozempic Novo Nordisk Insulin Therapy Drug Pricing Medication GLP-1 Medications Obesity Treatment Medication Misuse New Medications Metformin Weight Loss Injections Sales Performance Clinical Trials Semaglutide Weight-loss Drug GLP-1 Drugs Januvia

Frankfurt Medical Assistant Held Over Forged GLP‑1 Prescriptions Redeemed at 100+ Pharmacies

Prosecutors say forged GLP‑1 prescriptions created with a clinic’s software caused six‑figure insurer losses.

Serena Williams Says GLP-1 Treatment Helped Her Lose More Than 31 Pounds

Metformin Linked to Lower Dementia and Mortality Risks in Overweight, Obese Adults

Amagasaki Clinic Director Re-Arrested for Stealing Diabetes Medication

Study Investigates Vision Loss in Patients Using Popular Diabetes and Weight Loss Drugs

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

Eli Lilly Lowers 2024 Revenue Forecast as Weight-Loss Drug Sales Lag

Eli Lilly Announces $3 Billion Wisconsin Manufacturing Expansion

US Obesity Rates Projected to Surge by 2050

Senator Warren Urges FTC to Scrutinize Novo Holdings' $16.5B Catalent Acquisition

Alphabet Appoints Anat Ashkenazi as New CFO Amid AI Expansion

Youth Prescriptions for Weight Loss and Diabetes Drugs Surge Nearly 600%

Roche's Experimental Obesity Drug CT-388 Shows Significant Weight Loss in Early Trials

Eli Lilly's Weekly Insulin Matches Effectiveness of Daily Doses in Trials

U.S. Crude Oil Prices Surge Amid Supply Deficit Forecast and Geopolitical Tensions